COMMUNIQUÉS West-GlobeNewswire

Donations doubled on World Cancer Day to support Albertans with cancer

04/02/2025 - 15:45

Matching gift up to $200,000 announced, benefitting cancer patients in need of financial assistance EDMONTON, Alberta, Feb. 04, 2025 (GLOBE NEWSWIRE) -- This World Cancer Day (Tuesday, February 4), the Alberta Cancer [...]

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

04/02/2025 - 15:25

Jupiter, Florida, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL ™ , a patented resveratrol-based [...]

Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment

04/02/2025 - 15:05

Dr. Jennifer Kissner, SVP Clinical Development, discusses the 12-week safety and efficacy results for NORSE EIGHT clinical trial Watch the “What This Means” segment here ISELIN, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- [...]

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

04/02/2025 - 15:00

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease ONAPGO is a wearable subcutaneous infusion device that provides [...]

National Nonprofit SoldierStrong Announces 2024 Recipients of Annual Commitment to Service Award

04/02/2025 - 15:00

STAMFORD, Conn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit dedicated to helping military Veterans take their next steps forward in life after service through the donation of revolutionary [...]

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

04/02/2025 - 15:00

TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders [...]

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

04/02/2025 - 15:00

SAN DIEGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX) today announced that it has completed an assessment of its business and operations, including the [...]

PathAssist Derm Launches on AISight®: Advancing Dermatopathology Research Workflows using AI

04/02/2025 - 15:00

Now available on the AISight® Platform, PathAssist Derm is an AI-assisted histopathology tool that enhances dermatopathology research workflows, accelerating skin cancer research BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE [...]

Dror Ortho-Design Partners with Aran R&D to Advance Production

04/02/2025 - 15:00

JERUSALEM, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced a strategic partnership with Aran Research [...]

Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

04/02/2025 - 15:00

Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June 2024 ATLANTA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical [...]

Surplus Solutions Expands Global Offerings with Refurbished Analytical and Medical Equipment, Supported by New Brand and Website Launch

04/02/2025 - 14:49

WOONSOCKET, R.I., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions, a global leader in Equipment Lifecycle Management (ELM) services, specializing in procuring and reselling laboratory, processing, and packaging [...]

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

04/02/2025 - 14:35

Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025

04/02/2025 - 14:30

PRINCETON, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2024 financial results [...]

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

03/02/2025 - 22:45

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that [...]

Teladoc Health to Announce Fourth Quarter 2024 Financial Results

03/02/2025 - 22:30

PURCHASE, NY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release fourth quarter 2024 results on Wednesday, February 26, 2025, after the [...]

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/02/2025 - 22:30

WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

03/02/2025 - 22:30

HUNTSVILLE, Feb. 03, 2025 (GLOBE NEWSWIRE) -- S erina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, today announced the successful closing of the second $5 million tranche [...]

Olema Oncology to Participate in Upcoming Investor Conferences

03/02/2025 - 22:30

SAN FRANCISCO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]

Anaptys to Present at the Guggenheim SMID Cap Biotech Conference

03/02/2025 - 22:15

SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]